-+ 0.00%
-+ 0.00%
-+ 0.00%

RECKITT ANNOUNCES U.S. FDA APPROVAL OF MUCINEX® 12HR COLD & FEVER MULTI-SYMPTOM, THE FIRST OTC INNOVATION IN THE COLD & FLU CATEGORY IN 14 YEARS

Reuters·08/05/2026 13:05:00

Please log in to view news